Back
Evolus 10K Form
Buy
58
EOLS
Evolus
Last Price:
13.21
Seasonality Move:
18.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EOLS News And Ratings
See the #1 stock for the next 7 days that we like better than EOLS
EOLS Financial Statistics
Sales & Book Value
| Annual Sales: | $202.09M |
|---|---|
| Cash Flow: | $452K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.36 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.08000 |
|---|---|
| Net Income (TTM): | $-61.69M |
| Gross Margin: | $140.53M |
| Return on Equity: | 0% |
| Return on Assets: | -35.69% |
Evolus Earnings Forecast
Key Evolus Financial Ratios
- The Gross Profit Margin over the past 6 years for EOLS is 69.54%.
- The Selling, General & Administrative Expenses for EOLS have been equal to 81.62% of Gross Profit Margin.
- The Research & Development expenses have been 7.63% of Revenue.
- The Interest Expense is -22.42% of Operating Income.
- The Net Earning history of EOLS is -30.52% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 4 years.
Evolus Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | EOLS |
| CUSIP: | 30052C |
| Website: | evolus.com |
Debt
| Debt-to-Equity Ratio: | -5.82 |
|---|---|
| Current Ratio: | 2.33 |
| Quick Ratio: | 1.93 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 113.69 |